Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Optibrium Appoints Ian Smith as Chief Technology Officer (CTO)
Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the […]
ViroCell Strengthens Senior Management Team with Appointment of Nick Maishman as COO
ViroCell Biologics, founded by the UK’s most prolific academic viral vector manufacturing team, today announces […]
Dr. Cheryl Pegus, Former Walmart EVP of Health & Wellness, Joins Morgan Health
Dr. Cheryl Pegus, a nationally-recognized leader for her work to deliver affordable, high-quality care to millions of […]
Quell Therapeutics Appoints Luke Devey, BMBCh, Ph.D. as Chief Medical Officer
Quell Therapeutics Ltd, a world leader in developing engineered T-regulatory (Treg) cell therapies for serious […]
Optibrium Strengthens Global AI Drug Discovery Software Operations With Three Key Appointments
Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, today […]
Pfizer Completes Acquisition of Biohaven Pharmaceuticals
Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Biohaven Pharmaceutical Holding […]
Flagship Biosciences Hires Tom Turi, Ph.D., as New Chief Scientific Officer
Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the hiring […]
Cue Health Appoints Suzanne Stone as New Chief Commercial Officer
Cue Health Inc. (“Cue”) ( Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed Suzanne […]
Iain Mackay, Chief Financial Officer, to Retire From GSK, Julie Brown Appointed as Successor
GSK plc (LSE/NYSE: GSK) today announced that Iain Mackay, Chief Financial Officer (CFO), has decided […]
Pattern Health Closes $3.3M Series A to Expand Digital Health Research and Clinical Implementation Capabilities
Pattern Health, a digital health company, today announced the closing of a $3.3 million series A funding […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more